Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinson’s model miceKentaro Togashi, Toshio Ohshima, Yoshio Goshima et al.|Genes to Cells|2018Cited by 18
Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced mouse model of Parkinson's diseaseAine Tonouchi, Toshio Ohshima, Jun Nagai et al.|Journal of Neurochemistry|2016Cited by 12
Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activationKentaro Togashi, Toshio Ohshima, Kenneth Hensley et al.|Journal of the Neurological Sciences|2020Cited by 10